Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LubriSynHA is a healthcare company specializing in high-molecular-weight hyaluronic acid (HA) supplements for both human and animal health. Founded by world-renowned equine veterinarian Dr. Steven Allday, the company developed a proprietary liquid formulation designed to replenish synovial fluid and support joint cushion and lubrication. Their product portfolio includes specialized formulations for humans, performance horses, and household pets, focusing on non-invasive joint support. The company's primary value proposition lies in the high molecular weight of its HA, which is intended to mimic naturally occurring joint fluid more effectively than lower-weight alternatives. LubriSynHA operates primarily in the retail and veterinary distribution markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LubriSyn.